Sofiva Genomics Co Ltd (6615)

Currency in TWD
36.70
+1.90(+5.46%)
Closed·
Earnings results expected in 14 days
6615 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
34.8036.70
52 wk Range
28.9041.20
Key Statistics
Bid/Ask
51.60 / 52.50
Prev. Close
39.9
Open
34.8
Day's Range
34.8-36.7
52 wk Range
28.9-41.2
Volume
71.04K
Average Volume (3m)
44.94K
1-Year Change
-9.9387%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6615 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Sofiva Genomics Co Ltd Company Profile

Sofiva Genomics Co.,Ltd. provides pre-pregnancy, prenatal, and newborn genetic testing and medical testing services in Taiwan and internationally. The company offers reproductive testing services, including preimplantation genetic testing for aneuploidy (PGT-A), non-invasive preimplantation genetic testing for aneuploidy (niPGT-A), and preimplantation genetic testing for monogenic diseases (PGT-M); and prenatal testing services, such as non-invasive prenatal screening, array, karyotyping, maternal serum screening for down syndrome, risk assessment for early/late-onset preeclampsia, folate metabolism genetic testing, congenital infection screening,carrier scan, thalassemia genetic testing, spinal muscular atrophy genetic testing, and fragile X syndrome genetic testing. It also provides baby genetic testing comprising sensorineural hearing loss genetic testing; congenital central hypoventilation syndrome genetic testing (CCHS); and congenital cytomegalovirus infection testing (CMV). In addition, the company offers cancer screening services that include human papillomavirus screening (HPV); and hereditary cancer testing services. Further, it develops precision medicine genetic testing; and offers testing services to patients and carrier with rare disorders. Sofiva Genomics Co.,Ltd. was founded in 2012 and is based in Taipei, Taiwan.

Compare 6615 to Peers and Sector

Metrics to compare
6615
Peers
Sector
Relationship
P/E Ratio
−73.8x−0.9x−0.6x
PEG Ratio
0.50−1.820.00
Price/Book
1.2x−62.4x2.6x
Price / LTM Sales
1.9x7.9x3.3x
Upside (Analyst Target)
-40.4%44.5%
Fair Value Upside
Unlock5.4%5.0%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.47%
Dividend Yield
0.84%
Industry Median 0.66%
Annualized payout
0.30
Paid annually
5-Years Growth
-35.07%
Growth Streak

Earnings

Latest Release
Nov 13, 2025
EPS / Forecast
-0.05 / --
Revenue / Forecast
93.41M / --
EPS Revisions
Last 90 days

6615 Income Statement

FAQ

What Is the Sofiva Genomics (6615) Stock Price Today?

The Sofiva Genomics stock price today is 36.70 TWD.

What Stock Exchange Does Sofiva Genomics Trade On?

Sofiva Genomics is listed and trades on the Taipei Exchange.

What Is the Stock Symbol for Sofiva Genomics?

The stock symbol for Sofiva Genomics is "6615."

Does Sofiva Genomics Pay Dividends? What’s The Current Dividend Yield?

The Sofiva Genomics dividend yield is 0.84%.

What Is the Sofiva Genomics Market Cap?

As of today, Sofiva Genomics market cap is 751.45M TWD.

What Is Sofiva Genomics's Earnings Per Share (TTM)?

The Sofiva Genomics EPS (TTM) is -0.47.

When Is the Next Sofiva Genomics Earnings Date?

Sofiva Genomics will release its next earnings report on Mar 12, 2026.

From a Technical Analysis Perspective, Is 6615 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Sofiva Genomics Stock Split?

Sofiva Genomics has split 0 times.

What is the current trading status of Sofiva Genomics (6615)?

As of Feb 26, 2026, Sofiva Genomics (6615) is trading at a price of 36.70 TWD, with a previous close of 39.90 TWD. The stock has fluctuated within a day range of 34.80 TWD to 36.70 TWD, while its 52-week range spans from 28.90 TWD to 41.20 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.